In:
BioMed Research International, Hindawi Limited, Vol. 2022 ( 2022-10-7), p. 1-6
Kurzfassung:
Background. Patients with inflammatory bowel disease (IBD) have a decreased quality of life (QoL), the improvement of which is a treatment goal. The CUCQ-8 is a verified simple and effective QoL measurement tool. We validated the Korean version of CUCQ-8 with the approval of its developer. Methods. We investigated the correlation between the Korean version of CUCQ-8 and the IBDQ-32 in patients with IBD. Results. In all, 147 subjects (male, 97 (66.0%); female, 50 (34.0%); mean age 36.2 ± 13.5 years) were analyzed. Cronbach’s alpha coefficient of the CUCQ-8 was 0.833, indicating very high internal consistency. The Korean version of the CUCQ-8 showed a significant correlation with the IBDQ-32 and its subscales (correlation coefficient, 〉 0.75). Conclusions. The Korean version of the CUCQ-8 has high reliability and construct validity and can be used to evaluate the QoL of patients with IBD.
Materialart:
Online-Ressource
ISSN:
2314-6141
,
2314-6133
DOI:
10.1155/2022/9746899
Sprache:
Englisch
Verlag:
Hindawi Limited
Publikationsdatum:
2022
ZDB Id:
2698540-8